Academic Position:

17. Associate Professor in Hematology (Advanced & Molecular/Clinical Aspects) and Advanced Coagulation
    An-Najah National University, Nablus | 2015 – Present

• Recognized as among the top 0.5% of researchers in universities globally in the field of blood cells, according to the ScholarGPA 2024 ranking.
• H-index: 25 | i10-index: 41
• Focused on advancing knowledge in hematology, coagulation disorders, and blood cell pathophysiology.
• One of the founders of the Central Laboratory Research Lab and Animal House at the Faculty of Medicine.

• ---

Previous Academic Experience:

17. Assistant Professor – Clinical Hematology
    Al Quds University, Abu Dis – Jerusalem | 2008 – 2010

• Played a key role in the establishment of the university's first master’s program in Clinical Hematology.
• Designed course syllabi for the master’s program, with an emphasis on hematology, blood coagulation, and clinical biology.
• Instructed undergraduate and graduate courses in Hematology, Blood Coagulation, and Biology.
• Supervised and provided guidance to students on their graduation projects.

Teaching Experience:

17. Master’s/PhD Supervision:
    • Supervised and mentored Master's and PhD students at the Hebrew University, specifically in hematology and liver immunology at the Liver Institute-Hadassah Medical Center (2009-2022).
17. Teaching at An-Najah National University:
    • Instructed 3rd-year medical students, graduate (Master’s) , doctoral (PhD) students in medical sciences along with graduation projects of the 6^th year medical students.
    • Delivered courses in:
      • Hematology: Blood coagulation, leukemia, and anemia at both clinical and basic levels.
      • Cell Biology, Immunology, and Inflammation.
      • Research Methods and Research Seminars.

 

 

Education:

17. Post-Doctoral Researcher
    Weill Medical Center of Cornell, New York, USA & Hadassah Hebrew University Hospital, Jerusalem | 2006 – 2008
    Senior Researcher in Molecular and Clinical Hematology.
17. PhD in Hematology and Developmental Biology
    Hadassah Hebrew University Hospital, Jerusalem | 2001 – 2006
    Thesis: “Involvement of Oxidative Stress in Normal and Pathological Blood Cells: Relationship to Hemolysis, Hypercoagulable States, and Recurrent Infections.”
17. M.Sc. in Medical Health Technology and Clinical Microbiology
    Jordan University of Science and Technology, Jordan | 1997 – 2000
    Thesis: “Diagnostic Use of PCR for Detection of Pneumocystis carinii and Mycobacterium tuberculosis in Pulmonary Infections.”

17. B.Sc. in Medical Technology
    Amman University, Jordan | 1993 – 1997

 

Professional Training

• EASL- Explore innovations and discover transformative solutions for patient care in hepatology-Milano- Italy 2024
• EASL SLD Summit -Pargue-Cezchia 2023
• Post-graduate course (PGC) in “From NAFLD to Liver Cancer” – EASL, Vienna, Austria-2023.
• Symposium on China-Israel Innovative Medical Treatment, Bejing-China-2019.
• Alexion European WTX101-301 Investigator Meeting-Madrid, Spain-2019.
• Post-graduate course in “latest research in end-stage liver disease” – EASL, Vienna, Austria-2019.
• Workshop & Presentation in HCC monothematic conference – EASL – Lisbon, Portugal- 2019.
• Workshop & Presentation for the Gut-Liver Axis Monothematic Conference EASL – Leuven- Belgium-2018.
• Post-graduate course in “Viral hepatitis” – EASL, Paris, France-2018.
• Post-graduate course in “Emerging Trends in Non-Alcoholic Fatty Liver Disease” – AASLD, Washington, USA-2017.
• Post-graduate course in “A multidisciplinary approach to patients with liver disease” – EASL, Amsterdam, Netherlands-2017.
• Post-graduate course in “Management in liver tumors” –EASL, Barcelona, Spain-2016
• Good Laboratory Practice course-Omrix- Tel Hashomer Hospital, Tel Aviv -2015
• Post Graduate Course in “Metabolic Liver Disease” – EASL, Vienna, Austria – 2015
• Post-graduate course in “Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Disease: Advances in Diagnosis, Treatment and Clinical Practice “AASLD, Boston, USA – 2014
• Post-graduate course in “Chronic Viral Hepatitis”, EASL, London, UK – 2014
• Post-graduate course in “Liver Immunology”, AASLD, Washington, USA. 2013
• Post-graduate course in “Liver Alcohol Disease”, AASLD, Boston, USA. 2012
• Post-graduate course in “Cirrhosis”, AASLD, San Francisco. USA. 2011
• Post-graduate course in “Immunology and adaptive immune responses in HBV and HCV infections”, EASL, Berlin, Germany. 2011
• Course of “International GCP” (Good Clinical Practice) at Hadassah University Hospital. 2010
• Course and workshop in “Bioinformatics and gene expression”- University of Copenhagen-Denmark. 2009
• Course in “Management in Health and Medical Laboratories” – Tel-Aviv University. 2008-2009
• Visiting Fellow at Weill Medical Center of Cornell, New York, USA.  2004-2005 

Professional Affiliations

Member of the Palestinian Society of Laboratory Medicine

Israeli Ministry of Health – License to work at Medical Laboratories (License # 24642)

European Association Studies of Liver (EASL) – Member

American Association Studies of Liver Disease (AASLD) – Member

Israeli Ministry of Health – License for blood withdrawal and first aid

Israeli Medical Association – Member

The Israeli Association for Gastroenterology and Liver Diseases– Member

Israeli Ministry of Health – License and ethics to work with animal models

Honors and Awards

• 2024-An Najah University prize of the quality of research
• 2023-Abed Al Hamid prize of research excellency.
• 2022-An Najah University prize of the quality of research
• 2015- Best Abstract prize at the Israeli Association for liver study held in Eilat.
• 2014- Top 10 presidential poster at the AASLD conference held in Boston-USA entitled: “Insulin resistance of CD56dim NK cells decrease NK killing ability in NASH patients with advanced fibrosis”.
• 2012-The honor award of the “Young Investigator Scientist” for recognizing scientific research of the best scored abstract presented at the Presidential Plenary oral session, American Association Studies of Liver Disease (AASLD), Boston, Massachusetts-USA.

Topic: “Vitamin D levels in Nonalcoholic Fatty Liver Disease associate with Insulin resistance and Liver progression via a Novel NLG4 dependent NK recognition”.

• 2011- Grant of the EASL Young Investigators (Barcelona, Berlin, Amsterdam, Nice, Vienna, Prague, London).
• 2008- Grant of the trilateral cooperation (Israeli German-Palestinian).

• Participated in the planning of the new vaccination for hepatitis B (Sci-B VAC) of newborns in a tri-lateral program between Germany, Palestine and Israel.
• Coordinated the provision of the vaccine with the Palestinian Ministry of Health, East Jerusalem Hospitals (Augusta Victoria, Al Dajani Maternity Hospital).

• 2005- Travel Grant Award – Hadassah-Hebrew University Hospital-Jerusalem
• 2003-2004 Arab Israel Research Grant- Ministry of Science- Israel.

Organizing conferences

1. 1^st World Conference on Targeting Liver Diseases Sciences, Clinical Innovations & Biotechnology. June; 26-27, 2014 – Hadassah Medical Center -Jerusalem, Israel. http://www.targeting-liver.com/general-information/committee
2.      Jerusalem meeting for Liver Diseases Day, 24th March 2010.

 

CONTRIBUTION IN Research Grants

2010-2013  Chief Scientist Fund, “Immune modulation of Hepatic Fibrosis: New pathways for Lymphocytes and hepatic stellate cells interactions”, Approved on 5/1/2010, NIS 300000/year for 3 years.

2009-2013  Israel Scientific Foundation, “Immune modulation of Hepatic Fibrosis: New pathways for Lymphocytes and hepatic stellate cells interactions”, NIS 195000 a year for 4 years.

2009-2012  Deutsche Forschungsgemeinschaft German Research Foundation (DFG), a trilateral German/ Israeli/ Palestinian grant: “Improved Prevention of Perinatal hepatitis B transmission”, of total €1000000, my part is €283104 for 3 years.

2015-2016  Kamin- Ministry of Economy" The use of anti-neuroligin-4 (NLG4) receptor antibody to ameliorate hepatic fibrosis through enhance killing potentials of NK cells" total of 1 million NIS.

2019-2021 Ferring Pharmaceuticals- "The development of monoclonal antibody for educating NK cells for anti-fibrosis effects" total of 1 million NIS.

 

2019-2020 Can-Fite BioPharma- "Effects of Namodenoson (CF102) in an in vivo   mouse model of Diet-Induced obesity and insulin Resistance" $100000.

PEER REVIEWED Publications

https://scholar.google.com/citations?hl=en&user=FI-Al5UAAAAJ&view_op=list_works&sortby=pubdate

 

Languages

Arabic: Native Language

English: Fluent

Hebrew: Fluent

French: Good working knowledge

Computer Skills

Excellent command of Microsoft Office programs (Word, Excel, Power point …)